INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01FWFogarty Patrick W0B / 206S206 trades$1.10M
  2. 02Kurtz George0B / 202S202 trades$48.06M
  3. 03SPSaba Capital Management, L.P.67B / 19S · 11 late86 trades$21.51M
  4. 04NYNissan Yitzhak82B / 0S · 79 late82 trades$2.61M
  5. 05ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  6. 06AJAllaire Jeremy0B / 50S50 trades$4.26M
  7. 07Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  8. 08SJSheena Jonathan0B / 45S45 trades$3.01M
  9. 09SISarowitz Steven I2B / 34S36 trades$21.18M
  10. 10SLSpeiser Michael L0B / 35S35 trades$14.00M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 1732 insiders$917K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 179 insiders$893K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 178 insiders$2.77M
  7. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  8. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M

Form 4 transactions

73,372 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
7
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M$28K
133 sh
Dec 10, 2025Dec 12, 2025
Page 1645 of 1835
← PrevNext →
traded Dec 10, 2025
+2d
SEC Form 4

Evidence

6
CM
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
ANIPANI PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$33K
400 sh
Dec 12, 2025Dec 12, 2025
traded Dec 12, 2025
+0dSEC Form 4

Evidence

5
WG
Wright Robert G.EVP
DKDelek US Holdings, Inc.
Tax withholding
F$48K
1,382 sh
Dec 10, 2025Dec 12, 2025
traded Dec 10, 2025
+2dSEC Form 4

Evidence

5
RJ
Rubino Andrew JChief Operating Officer
TFSLTFS Financial CORP
Option exercise
M—
2,167 sh
Dec 10, 2025Dec 12, 2025
traded Dec 10, 2025
+2dSEC Form 4

Evidence

5
RJ
Rubino Andrew JChief Operating Officer
TFSLTFS Financial CORP
Option exercise
M—
2,134 sh
Dec 10, 2025Dec 12, 2025
traded Dec 10, 2025
+2dSEC Form 4

Evidence

5
PT
Power Luke ThomasSee Remarks
CAICaris Life Sciences, Inc.
Open-market sale · 10b5-1 plan
SELL$38K
1,400 sh
Dec 11, 2025Dec 12, 2025
traded Dec 11, 2025
+1dSEC Form 4

Evidence

5
PB
Pfeiffenberger BrentDirector, President and CEO
IPSCCentury Therapeutics, Inc.
Tax withholding
F$244
463 sh
Dec 10, 2025Dec 12, 2025
traded Dec 10, 2025
+2dSEC Form 4

Evidence

5
RJ
Rubino Andrew JChief Operating Officer
TFSLTFS Financial CORP
Option exercise
M—
8,730 sh
Dec 10, 2025Dec 12, 2025
traded Dec 10, 2025
+2dSEC Form 4

Evidence

4
AT
Arora TarunChief Accounting Officer
RNGRingCentral, Inc.
Open-market sale · 10b5-1 plan
SELL$79K
2,597 sh
Dec 10, 2025Dec 12, 2025
traded Dec 10, 2025
+2dSEC Form 4

Evidence

3
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M$16K
98 sh
Dec 11, 2025Dec 12, 2025
traded Dec 11, 2025
+1dSEC Form 4

Evidence

3
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M$16K
98 sh
Dec 10, 2025Dec 12, 2025
traded Dec 10, 2025
+2dSEC Form 4

Evidence

0
Narkhede NehaDirector
CFLTConfluent, Inc.
Option exercise · 10b5-1 plan
M—
23.1K sh
Dec 10, 2025Dec 12, 2025
traded Dec 10, 2025
+2dSEC Form 4

Evidence

0
RM
Rizik MatthewDirector
RKTRocket Companies, Inc.
Open-market sale · 10b5-1 plan
SELL$48K
2,500 sh
Dec 10, 2025Dec 12, 2025
traded Dec 10, 2025
+2dSEC Form 4

Evidence

0
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M$20K
101 sh
Dec 10, 2025Dec 12, 2025
traded Dec 10, 2025
+2dSEC Form 4

Evidence

0
WT
Weingarten TomerDirector, President, CEO
SSentinelOne, Inc.
Derivative conversion · 10b5-1 plan
C—
5,441 sh
Dec 11, 2025Dec 12, 2025
traded Dec 11, 2025
+1dSEC Form 4

Evidence

0
RM
Rizik MatthewDirector
RKTRocket Companies, Inc.
Open-market sale · 10b5-1 plan
SELL$49K
2,500 sh
Dec 11, 2025Dec 12, 2025
traded Dec 11, 2025
+1dSEC Form 4

Evidence

0
Narkhede NehaDirector
CFLTConfluent, Inc.
Option exercise · 10b5-1 plan
M—
23.1K sh
Dec 10, 2025Dec 12, 2025
traded Dec 10, 2025
+2dSEC Form 4

Evidence

0
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M—
1,729 sh
Dec 11, 2025Dec 12, 2025
traded Dec 11, 2025
+1dSEC Form 4

Evidence

0
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M—
1,274 sh
Dec 11, 2025Dec 12, 2025
traded Dec 11, 2025
+1dSEC Form 4

Evidence

0
PT
Power Luke ThomasSee Remarks
CAICaris Life Sciences, Inc.
Option exercise · 10b5-1 plan
M—
24.8K sh
Dec 11, 2025Dec 12, 2025
traded Dec 11, 2025
+1dSEC Form 4

Evidence

0
PT
Power Luke ThomasSee Remarks
CAICaris Life Sciences, Inc.
Option exercise · 10b5-1 plan
M—
37.5K sh
Dec 11, 2025Dec 12, 2025
traded Dec 11, 2025
+1dSEC Form 4

Evidence

0
Narkhede NehaDirector
CFLTConfluent, Inc.
Derivative conversion · 10b5-1 plan
C—
23.1K sh
Dec 10, 2025Dec 12, 2025
traded Dec 10, 2025
+2dSEC Form 4

Evidence

0
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M—
1,274 sh
Dec 10, 2025Dec 12, 2025
traded Dec 10, 2025
+2dSEC Form 4

Evidence

0
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M—
1,313 sh
Dec 10, 2025Dec 12, 2025
traded Dec 10, 2025
+2dSEC Form 4

Evidence

0
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M—
1,729 sh
Dec 10, 2025Dec 12, 2025
traded Dec 10, 2025
+2dSEC Form 4

Evidence

0
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M—
1,313 sh
Dec 11, 2025Dec 12, 2025
traded Dec 11, 2025
+1dSEC Form 4

Evidence

0
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M$20K
101 sh
Dec 11, 2025Dec 12, 2025
traded Dec 11, 2025
+1dSEC Form 4

Evidence

0
WT
Weingarten TomerDirector, President, CEO
SSentinelOne, Inc.
Derivative conversion · 10b5-1 plan
C—
5,441 sh
Dec 11, 2025Dec 12, 2025
traded Dec 11, 2025
+1dSEC Form 4

Evidence

0
RM
Rizik MatthewDirector
RKTRocket Companies, Inc.
Open-market sale · 10b5-1 plan
SELL$47K
2,500 sh
Dec 12, 2025Dec 12, 2025
traded Dec 12, 2025
+0dSEC Form 4

Evidence

49
KL
Kirchhoff Benjamin LouisCHIEF ACCOUNTING OFFICER
IOTSamsara Inc.
Open-market sale
SELL$72K
1,609 sh
Dec 10, 2025Dec 11, 2025
traded Dec 10, 2025
+1dSEC Form 4

Evidence

48
PD
Phillips DominicSEE REMARKS
IOTSamsara Inc.
Open-market sale
SELL$366K
8,231 sh
Dec 10, 2025Dec 11, 2025
traded Dec 10, 2025
+1dSEC Form 4

Evidence

48
EA
Eltoukhy AdamSEE REMARKS
IOTSamsara Inc.
Open-market sale
SELL$422K
9,498 sh
Dec 10, 2025Dec 11, 2025
traded Dec 10, 2025
+1dSEC Form 4

Evidence

45
KL
Keene Harold LDirector, 10% Owner
NWPPNEW PEOPLES BANKSHARES INC
Open-market purchase
BUY$208K
57.1K sh
Dec 11, 2025Dec 11, 2025
traded Dec 11, 2025
+0dSEC Form 4

Evidence

45
WS
White Blaine ScottDirector, 10% Owner
NWPPNEW PEOPLES BANKSHARES INC
Open-market purchase
BUY$370K
101.5K sh
Dec 10, 2025Dec 11, 2025
traded Dec 10, 2025
+1dSEC Form 4

Evidence

42
Xu TonyDirector, CHIEF EXECUTIVE OFFICER, 10% Owner
DASHDoorDash, Inc.
Open-market sale · 10b5-1 plan
SELL$3.83M
16.7K sh
Dec 9, 2025Dec 11, 2025
traded Dec 9, 2025
+2dSEC Form 4

Evidence

41
BP
Benedict PeterCHIEF INFORMATION OFFICER
USNAUSANA HEALTH SCIENCES INC
Open-market sale
SELL$56K
2,673 sh
Dec 10, 2025Dec 11, 2025
traded Dec 10, 2025
+1dSEC Form 4

Evidence

40
SK
Stueland KatherineDirector, CHIEF EXECUTIVE OFFICER
WGSGeneDx Holdings Corp.
Open-market sale
SELL$580K
3,639 sh
Dec 9, 2025Dec 11, 2025
traded Dec 9, 2025
+2dSEC Form 4

Evidence

40
TK
Talvitie KristianEVP, Chief Financial Officer
PTCPTC INC.
Open-market sale
SELL$6.93M
40.1K sh
Dec 9, 2025Dec 11, 2025
traded Dec 9, 2025
+2dSEC Form 4

Evidence

39
MJ
Malloy Brian JPresident and COO
CRSCARPENTER TECHNOLOGY CORP
Open-market sale
SELL$1.55M
5,061 sh
Dec 9, 2025Dec 11, 2025
traded Dec 9, 2025
+2dSEC Form 4

Evidence

39
TS
Tolda StelleoDirector
MELIMERCADOLIBRE INC
Open-market sale
SELL$504K
246 sh
Dec 9, 2025Dec 11, 2025
traded Dec 9, 2025
+2dSEC Form 4

Evidence